NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells-Reference-Cited by-同舟云学术

NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells

Published:2016-10-11 Issue:1 Volume:7 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Ratajczak Joanna,Joffraud Magali,Trammell Samuel A. J.,Ras Rosa,Canela Núria,Boutant Marie,Kulkarni Sameer S.,Rodrigues Marcelo,Redpath Philip,Migaud Marie E.,Auwerx Johan,Yanes Oscar^ORCID,Brenner Charles^ORCID,Cantó Carles^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms13103.pdf

Reference46 articles.

1. Belenky, P., Bogan, K. L. & Brenner, C. NAD+ metabolism in health and disease. Trends Biochem. Sci. 32, 12–19 (2007).

2. Bogan, K. L. & Brenner, C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu. Rev. Nutr. 28, 115–130 (2008).

3. Canto, C., Menzies, K. J. & Auwerx, J. NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 22, 31–53 (2015).

4. Haigis, M. C. & Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253–295 (2010).

5. Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225–238 (2012).

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nicotinamide riboside kinase 2: A unique target for skeletal muscle and cardiometabolic diseases;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers;Cancers;2024-09-05

3. Nicotinamide Mononucleotide: Research Process in Cardiovascular Diseases;International Journal of Molecular Sciences;2024-09-02

4. NAD+ metabolism and therapeutic strategies in cardiovascular diseases;Atherosclerosis Plus;2024-09

5. The Fluorinated NAD Precursors Enhance FK866 Cytotoxicity by Activating SARM1 in Glioblastoma Cells;Biology;2024-08-23